Leen Ann M.

CIK 00017630262 companiesJACKSONVILLE, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001763026

Recent Transactions

36 trades

Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2023-02-02+81,250→ 473,594 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-02+43,750→ 124,006 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+15,000→ 43,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+26,000→ 392,344 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+14,000→ 65,256 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+23,256→ 51,256 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+56,744→ 366,344 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-11-16$21.76/sh−100→ 2,288,154 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-11-15$21.92/sh−6,122→ 2,288,254 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-11-12$22.26/sh−14,266→ 2,294,876 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-11-12$23.18/sh−500→ 2,294,376 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-05-10$22.75/sh−150,000→ 2,309,142 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-16$30.00/sh−3,025→ 2,459,142 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$38.46/sh−6,359→ 2,465,326 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$39.18/sh−3,159→ 2,462,167 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$39.59/sh−1,907→ 2,472,485 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$40.56/sh−800→ 2,471,685 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$38.83/sh−1,492→ 2,474,392 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$42.84/sh−4,506→ 2,475,884 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$41.54/sh−1,200→ 2,480,390 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-19$41.75/sh−7,541→ 2,481,590 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$41.50/sh−1,300→ 2,489,131 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$40.44/sh−1,100→ 2,490,431 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$39.20/sh−300→ 2,491,531 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$39.85/sh−400→ 2,493,217 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$38.63/sh−500→ 2,493,617 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$41.28/sh−1,386→ 2,491,831 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$41.82/sh−2,850→ 2,494,317 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$42.79/sh−200→ 2,494,117 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-01-19+28,000→ 28,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-01-19+52,000→ 52,000 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-11-30−60,394→ 0 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-11-30+60,394→ 60,394 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03+2,436,773→ 2,436,773 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Series A-3 Convertible Preferred Stock
2020-08-03−3,631,293→ 0 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+257,600→ 257,600 total

Companies

Recent Filings

Address

5 WEST FORSYTH STREET SUITE 200

JACKSONVILLE, FL, 32202

View on SEC.gov